Dora Ding
Impact in
- Hepatology top 5%
- Liver Diseases and Immunity
- Liver physiology and pathology
- Liver Disease and Transplantation
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
Papers in
-
- Liver Disease Diagnosis and Treatment 9
-
- Liver Diseases and Immunity 3
- Co-authors
- Robert P. Myers (5 shared papers)Zachary D Goodman (4 shared papers)Andrew Joseph Muir (4 shared papers)Nezam H. Afdhal (2 shared papers)Catherine Jia (3 shared papers)Ryan S. Huss (2 shared papers)Chuhan Chung (2 shared papers)Eric Lawitz (2 shared papers)
- Journals
- Journal of Hepatology (4 papers)Hepatology (3 papers)Diabetes Obesity and Metabolism (1 paper)Clinical Gastroenterology and Hepatology (1 paper)European Journal of Internal Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Dora Ding
11 papers receiving 685 citations
Dora Ding's Hit Papers
Peers
Comparison fields: 5 of 43
- Hepatology 211
- Epidemiology 423
- Oncology 31
- Pharmacology 11
- Cancer Research 14
Countries citing papers authored by Dora Ding
This map shows the geographic impact of Dora Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Ding more than expected).
Fields of papers citing papers by Dora Ding
This network shows the impact of papers produced by Dora Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Ding. The network helps show where Dora Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH Hit paper breakdown → | 2020 | 249 |
| 2 | 2018 | 164 | |
| 3 | 2021 | 130 | |
| 4 | 2022 | 84 | |
| 5 | 2022 | 41 | |
| 6 | 2016 | 9 | |
| 7 | 2020 | 9 | |
| 8 | 2023 | 5 | |
| 9 | 2017 | 4 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 1 | |
| 12 | 2025 | 0 |
About Dora Ding
Dora Ding is a scholar working on Epidemiology, Hepatology, Pharmacology, Oncology and Nuclear Energy and Engineering, having authored 12 papers that have together received 699 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Liver Diseases and Immunity (3 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Hepatology (211 citations), Epidemiology (423 citations), Oncology (31 citations), Pharmacology (11 citations) and Cancer Research (14 citations). Dora Ding has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Robert P. Myers, Zachary D Goodman, Andrew Joseph Muir, Nezam H. Afdhal, Catherine Jia, Ryan S. Huss, Chuhan Chung, Eric Lawitz, John G. McHutchison and Velimir A. Luketic. Their work appears in journals such as Journal of Hepatology, Hepatology, Diabetes Obesity and Metabolism, Clinical Gastroenterology and Hepatology and European Journal of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.